Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 4/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | APLNR | P35414 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 2/20 | 0.39 |
| ▸ | CTSK | P43235 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KDM4A | O75164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28690736 | 0.85 | TDP1 (0.47) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL27801417 | 0.82 | TDP1 (0.50) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL166624 | 0.82 | TDP1 (0.58) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL11989021 | 0.80 | TDP1 (0.55) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL3341020 | 0.80 | TDP1 (0.67) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL166207 | 0.79 | TDP1 (0.65) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL7365542 | 0.79 | TDP1 (0.34) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL605531 | 0.78 | TDP1 (0.53) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL605532 | 0.78 | TDP1 (0.59) | TDP1MEN1GAAKMT2AMAOA | |
| SCHEMBL12138378 | 0.78 | TDP1 (0.53) | TDP1MEN1GAAKMT2AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024131265-A1 | COMPOUND FOR TREATING PI3Kγ-MEDIATED DISEASES AND USE THEREOF | 中国科学院合肥物质科学研究院 | 2024-06-27 | — | — | WO | claimed |
| CN-118239953-A | Compounds for the treatment of PI3K gamma mediated diseases and uses thereof | 中国科学院合肥物质科学研究院 | 2024-06-25 | — | — | CN | claimed |
| US-12018021-B2 | Thiophene derivatives for the treatment of disorders caused by IgE | UCB Biopharma SRL (BE) | 2024-06-25 | — | — | US | claimed |
| CN-117298108-A | Androgen receptor and glucocorticoid receptor dual-target inhibitor and application thereof | 浙江师范大学 | 2023-12-29 | — | — | CN | claimed |
| US-20230126415-A1 | OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF | AKAGERA MEDICINES, INC. (US) | 2023-04-27 | — | — | US | claimed |
| CN-114805367-B | Triazole pyrimidine derivative and preparation method and application thereof | 郑州大学 | 2023-04-07 | — | — | CN | claimed |
| CN-115803333-A | Trinucleotide cap analogs, their preparation and use | 生命技术公司 | 2023-03-14 | — | — | CN | claimed |
| CN-111527088-B | Amino-methylpiperidine derivatives as kinase inhibitors | 株式会社大熊制药 | 2022-12-30 | — | — | CN | claimed |
| CN-114805367-A | Triazole pyrimidine derivative and preparation method and application thereof | 郑州大学 | 2022-07-29 | — | — | CN | claimed |
| EP-3733674-B1 | AMINO-METHYL PIPERIDINE DERIVATIVE AS KINASE INHIBITOR | DAE WOONG PHARMA (KR) | 2022-06-29 | — | — | EP | claimed |
| WO-1987003478-A2 | MEDICAMENTS | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSC (DE) | 1987-06-18 | — | — | WO | claimed |
| WO-1987003596-A2 | NOVEL PHOSPHO-COMPOUNDS AND MEDICAMENTS CONTAINING THESE | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSC (DE) | 1987-06-18 | — | — | WO | claimed |
| EP-0225608-A2 | Medicine | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1987-06-16 | — | — | EP | claimed |
| EP-0224925-A2 | Phosphorous compounds and medicines containing them | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1987-06-10 | — | — | EP | claimed |
| EP-0042154-B1 | NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-04-15 | — | — | EP | claimed |
| US-4495182-A | TREATMENT OF INFECTIOUS DISEASES;CEPHALOSPORINS AND DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-01-22 | — | — | US | claimed |
| EP-0007470-B1 | CEPHEM COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-12 | — | — | EP | claimed |
| EP-0069872-A2 | New cephem compounds and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-01-19 | — | — | EP | claimed |
| US-4268509-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-05-19 | — | — | US | claimed |
| EP-0007470-A2 | Cephem compounds, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-02-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230126415-A1 | OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF | OXA1L, THPO, TBCD | TDP1 3897/4885MEN1 1371/4885GAA 1148/4885 |
| US-12018021-B2 | Thiophene derivatives for the treatment of disorders caused by IgE | TSLP, CYSLTR1, CYSLTR2 | TDP1 1193/4885MEN1 2963/4885GAA 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.